Viewing nowSimvast Tablets 40 mg (Simvastatin)
Simvastatin 40mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200402617 · Notified 2004.03.19 · Insurance code 643501470
Improvement of hyperlipidemia (including pediatric heterozygous familial hypercholesterolemia); prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular disease. It specifically decreases the risk of death due to coronary heart disease in adult patients with a history of coronary artery disease, diabetes, peripheral vascular disease, or stroke, while reducing the risk of non-fatal myocardial infarctions and strokes, as well as risks associated with vascular surgeries. It also aids in managing cholesterol and triglyceride levels in patients with hyperlipidemia, maintaining healthy blood lipid levels. It can be used alongside dietary therapy in patients with primary hypercholesterolemia and dyslipidemia and is also beneficial for certain types of familial hypercholesterolemia. In children aged 10 to 17 who meet specific conditions, it serves as an adjunct to dietary therapy. This medication is used to improve cardiovascular health and treat hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with coronary heart disease and hypercholesterolemia, and treatment of hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity, particularly during the first year of treatment (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving concomitant fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Use This Medicine under Precautions for Use) and fenofibrate), the dose must not exceed 10 mg per day. (6) Use in patients with renal impairment Since this medicine is not substantially excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start treatment at 5 mg per day and monitor carefully.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose for each patient as appropriate according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication may cause muscle-related side effects such as myopathy or rhabdomyolysis, so caution is advised, especially when taking high doses. Patients with an allergy to this medication or its ingredients, those with liver dysfunction, pregnant or breastfeeding women, and those taking certain medications should not take this drug. Patients with impaired liver function or kidney issues, those with hypothyroidism or a history of muscle disorders, elderly patients, and women should use this medication with care. If muscle pain, muscle weakness, or unexplained muscle soreness occurs during treatment, consult your physician immediately, as discontinuation may be necessary in some cases. Since this medication is metabolized in the liver, patients with liver dysfunction should undergo regular liver function tests, and those with a history of liver disease should be particularly cautious. This medication may interact with multiple drugs, so inform your physician or pharmacist if you are taking other medications, especially when combined with certain antifungals, antibiotics, immunosuppressants, calcium channel blockers, or niacin. Women who are pregnant or may become pregnant should not take this medication, and if pregnancy occurs during treatment, it should be stopped immediately, and a physician should be consulted. This drug is also used in children and adolescents, but safety in children under 10 has not been established, hence it should not be administered to this age group. Elderly patients may have higher blood levels of this medication, necessitating dosage adjustments and careful monitoring. In case of overdose, specific antidotes are not available; general treatment is required, and this medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius.
Oval film-coated tablet of red brick color
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 40mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.